Asako McCloskey

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Transcription Factor

Top Venues

Science (New York, N.Y.)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Zocher, Asako McCloskey, Anne Karasinsky, Roberta Schulte, Ulrike Anne Friedrich, Matthias Lesche, Nicole Rund, Fred H Gage, Martin W Hetzer, Tomohisa Toda
Lifelong persistence of nuclear RNAs in the mouse brain. Science (New York, N.Y.) 384 (6691) (2024)
Sara Zocher, Asako McCloskey, Anne Karasinsky, Roberta Schulte, Ulrike Anne Friedrich, Matthias Lesche, Nicole Rund, Fred H Gage, Martin W Hetzer, Tomohisa Toda
Lifelong persistence of nuclear RNAs in the mouse brain. Science (New York, N.Y.) 384 (6691) (2024)
Sara Zocher, Asako McCloskey, Anne Karasinsky, Roberta Schulte, Ulrike Anne Friedrich, Matthias Lesche, Nicole Rund, Fred H Gage, Martin W Hetzer, Tomohisa Toda
Lifelong persistence of nuclear RNAs in the mouse brain. Science (New York, N.Y.) 384 (6691) (2024)
Sara Zocher, Asako McCloskey, Anne Karasinsky, Roberta Schulte, Ulrike Anne Friedrich, Matthias Lesche, Nicole Rund, Fred H Gage, Martin W Hetzer, Tomohisa Toda
Lifelong persistence of nuclear RNAs in the mouse brain. Science (New York, N.Y.) 384 (6691) (2024)
Sara Zocher, Asako McCloskey, Anne Karasinsky, Roberta Schulte, Ulrike Anne Friedrich, Matthias Lesche, Nicole Rund, Fred H Gage, Martin W Hetzer, Tomohisa Toda
Lifelong persistence of nuclear RNAs in the mouse brain. Science (New York, N.Y.) 384 (6691) (2024)
Alison E Smith, Stacia Chan, Zhiyong Wang, Asako McCloskey, Quinn Reilly, Jayden Z Wang, Hetika Vora Patel, Keiichi Koshizuka, Harris S Soifer, Linda Kessler, Ashley Dayoub, Victoria M Villaflor, Douglas R Adkins, Justine Yang Bruce, Alan L Ho, Cesar A Perez, Glenn J Hanna, Amaya Gasco Hernandez, Andrew Saunders, Stephen Dale, Jorge Silvio Gutkind, Francis Burrows, Shivani Malik
Tipifarnib potentiates the antitumor effects of PI3Kα inhibition in PIK3CA- and HRAS-dysregulated HNSCC via convergent inhibition of mTOR activity. Cancer research (2023)